Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1Î±, for the Treatment of Psoriasis.

JAMA Dermatol. 2015 May;151(5):555-6

{{ author.authorName }}^{{{getOrganisationIndexOf(author)}}} {{ author.authorName }}^{{{getOrganisationIndexOf(author)}}}

+ et al

[No authors listed]

Author information

null

KEYWORDS: {{ getKeywords(articleDetailText.words) }}

‹ › ×

Sample name	Organism	Experiment title	Sample type	Library instrument	Attributes
Sample name	Organism	Experiment title	Sample type	Library instrument	{{attr}}
{{ dataList.sampleTitle }}	{{ dataList.organism }}	{{ dataList.expermentTitle }}	{{ dataList.sampleType }}	{{ dataList.libraryInstrument }}	{{ showAttributeName(index,attr,dataList.attributes) }}